-
221
The theses for MD degree
Published 2011-02-01“…Idrisova – Value of a latent HBV-infection in progression of chronic liver diseases.T.A. Batyukhno - Chronic pancreatitis: disorders of protective immune mechanisms and their pharmacological treatment.S.P. …”
Get full text
Article -
222
-
223
The theses for MD degree
Published 2014-11-01“…Schyokotova — Clinical and laboratory parameters and endothelial dysfunction at liver diseases, their diagnostic, prognostic value and potential of application for treatment response rate ratingA.A. …”
Get full text
Article -
224
Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
Published 2012-11-01“…To study the functional changes of cardio-vascular system in patients with viral liver diseases.Material and methods. Overall 150 patients with hepatitis virus C-associated liver diseases, including 80 patients with chronic hepatitis and 70 – with liver cirrhosis (LC) have been included in original study. …”
Get full text
Article -
225
A 19-year-old Patient with Recurrent Pruritus and Jaundice
Published 2023-09-01“…Identification of etiology of cholestatic liver diseases requires broad differential diagnosis. …”
Get full text
Article -
226
Review of the European <i>Helicobacter</i> Study Group Workshop reports (Ljubljana, 2012)
Published 2013-07-01“…Possible correlations of H. pylori infection with rate of various diseases development – both positive (colorectal cancer, liver diseases, Alzheimer's disease), and negative (gastroesophageal reflux disease, adenocarcinoma of the esophagus, chronic inflammatory bowel diseases, bronchial asthma) continue to be studied. …”
Get full text
Article -
227
A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024)
Published 2025-02-01“…Abstract Objective This study aimed to analyze the characteristics of patients undergoing percutaneous liver biopsies and investigate the pathological manifestations of four major liver diseases across different age groups. Methods A retrospective analysis was conducted of 4,717 liver pathology reports from 2009 to 2024. …”
Get full text
Article -
228
-
229
Stem cells in gastroenterology: prospects and problems
Published 2011-12-01“…In therapeutic aspect of gastrointestinal and liver diseases inflammatory bowel diseases, colorectal cancer and decompensated liver cirrhosis seem to be most perspective at the present stage. …”
Get full text
Article -
230
Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
Published 2010-02-01“…Decrease of severity of fibrosis (for prophylaxis of liver cirrhosis and hepatocellular carcinoma development) is one of the basic criteria of efficacy of treatment of chronic liver diseases. Now various strategies of influence on fibrosis are discussed, including elimination of etiological factor, suppression of inflammation and specific antifibrotic therapy.Conclusion. …”
Get full text
Article -
231
Critical evaluation of pathogenic factors of primary biliary cirrhosis
Published 2013-07-01“…Primary biliary cirrhosis (PBC) is related to the group of autoimmune cholestasisassociated liver diseases. In the last years prevalence of PBC increased considerably, especially – in Northern European countries. …”
Get full text
Article -
232
Radiological diagnostic methods in gastroenterology
Published 2018-08-01“…Radiological signs at chronic diffuse liver diseases, disorders of portal blood flow and associated extrahepatic hemodynamic disorders are present. …”
Get full text
Article -
233
PLIN5 contributes to lipophagy of hepatic stellate cells induced by inorganic arsenic
Published 2025-01-01“…This research offers a novel perspective on the mechanisms of arsenic-induced HSCs activation and liver lipid metabolism, potentially guiding new strategies for the prevention and treatment of arsenic-related liver diseases.…”
Get full text
Article -
234
Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis
Published 2011-12-01“…Obtained data assume, that infiltration of the liver by leukocytes, in particular neutrophiles, in combination to ascending necrotic destruction of peripheral cells of innate and adaptive immunity can be the essential pathogenic mechanism at inflammatory liver diseases of T-cell origin.…”
Get full text
Article -
235
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
Published 2025-01-01“…The study highlights the interplay between α-amanitin, NLRP3, and PPAR-γ in hepatotoxicity, proposing potential therapeutic targets for mushroom poisoning-induced liver diseases.…”
Get full text
Article -
236
Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
Published 2014-09-01“…Hepatocellular carcinoma is one of the most dreadful outcomes of chronic liver diseases, in particular — chronic hepatitis C (CHC). …”
Get full text
Article -
237
Efficacy of TIPS plus extrahepatic collateral embolisation in real-world data: a validation study
Published 2024-05-01Get full text
Article -
238
-
239
Issues occult hepatitis B virus infection
Published 2012-07-01“…With the help of up-to-date molecular-biological and morphological methods to determine frequency of the occult form of chronic hepatitis B (CHB) among HBsAg-negative patients with chronic liver diseases (CLD) of various etiology and to present clinical and morphological characteristic.Material and methods. …”
Get full text
Article -
240
Liver macrophage-derived exosomal miRNA-342-3p promotes liver fibrosis by inhibiting HPCAL1 in stellate cells
Published 2025-02-01“…Conclusion This study reveals a previously unidentified profibrotic mechanism of crosstalk between macrophages and HSCs in the liver and suggests an attractive novel therapeutic strategy for treating fibroproliferative liver diseases. Graphical Abstract…”
Get full text
Article